Water → (+/-)-cis-({3-[(6-Phenylfuro[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}oxy)acetic acid tert-butyl ester

HRID 2189037Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2189037
[C:1]1([C:7]2[O:23][C:10]3[N:11]=[CH:12][N:13]=[C:14]([NH:15][C@@H:16]4[CH2:21][CH2:20][CH2:19][C@H:18]([OH:22])[CH2:17]4)[C:9]=3[CH:8]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[OH-].[Na+].[C:26]([O:30][C:31](=[O:34])[CH2:32]Br)([CH3:29])([CH3:28])[CH3:27].O>S([O-])(O)(=O)=O.C([N+](CCCC)(CCCC)CCCC)CCC.C1(C)C=CC=CC=1.C1COCC1>[C:26]([O:30][C:31](=[O:34])[CH2:32][O:22][C@H:18]1[CH2:19][CH2:20][CH2:21][C@@H:16]([NH:15][C:14]2[C:9]3[CH:8]=[C:7]([C:1]4[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=4)[O:23][C:10]=3[N:11]=[CH:12][N:13]=2)[CH2:17]1)([CH3:29])([CH3:28])[CH3:27]

Komponenten

8

Reaktionsbedingungen

Temperatur
70 °C

Versuchsvorschrift

At 40° C., add approx. 0.06 mmol of tetrabutylammonium hydrogensulphate and a solution of 200 mg (0.646 mmol) of (+/−)-cis-3-[(6-phenylfuro[2,3-d]pyrimidin-4-yl)amino]cyclohexanol in 0.5 ml of toluene and 0.1 ml of THF to a mixture of 517 mg of 50% sodium hydroxide solution (6.5 mmol) and 0.5 ml of toluene. Admix the resulting mixture with 0.19 ml (1.29 mmol) of bromoacetic acid tert-butyl ester with vigorous stirring and heat it to 70° C. After 2 h, cool the mixture and add it to water. Extract three times with dichloromethane, wash the combined organic phases with saturated sodium chloride solution and concentrate under reduced pressure. After preparative RP-HPLC (eluent: acetonitrile/water), 152 mg (55.5% of theory) of the target product are isolated from the crude product.

Aufarbeitung

  1. temperaturecool the mixture
  2. extractionExtract three times with dichloromethane
  3. washwash the combined organic phases with saturated sodium chloride solution
  4. concentrationconcentrate under reduced pressure

Quellen und Nachweise

ORD-Eintrag
ord-b14def8bf2cc47f3aa2c0a7633a384bc
Quelldatensatz
uspto-grants-2012_12
Patentnummer
US08324222B2

Notizen zur Reaktion

Wird geladen…